CAUSAL GENES AND PATHOGENIC MECHANISMS UNDERLYING GASTROINTESTINAL DISEASES
Professor Mauro D’Amato
Professor of Medical Genetics, Department of Medicine and Surgery,
LUM University in Casamassima, Italy &
Ikerbasque Research Professor and Head of the Gastrointestinal Genetics Lab
CIC bioGUNE, Derio, Spain
RESEARCHER PROFILE
Filmed online | January 2025
Mauro D’Amato is Professor of Medical Genetics at the Department of Medicine and Surgery at LUM University in Casamassima – Italy, and Ikerbasque Research Professor and Head of the Gastrointestinal Genetics Lab in CIC bioGUNE, Derio – Spain. His career has developed through an important international trajectory, holding research and academic positions at several institutions including the Wellcome Trust Center for Human Genetics in Oxford – UK, the Karolinska Institutet in Stockholm – Sweden, Biodonostia HRI in San Sebastian – Spain and Monash University in Melbourne – Australia.
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
He is also the coordinator of the bellygenes initiative on the genetics of IBS, and biobank-scale research from his lab contributes to multiple scientific consortia and collaborative networks studying the genetic makeup of millions of people across EU, USA and Australasia.
Professor D’Amato has an H-index of 74, has edited 2 books and published extensively in the field of human genetics and gastrointestinal disease; he provides expert feedback to international journals and research funding agencies, and has supervised more than 40 PhD students and postdocs.
https://orcid.org/0000-0003-2743-5197
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
-
Novel immunotherapies in lymphoma
Dr Sean Harrop is a dual-trained haematologist having completed his clinical and laboratory haematology training at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and St Vincent’s Hospital Melbourne. He is the current clinical haematology fellow (aggressive lymphoma) at Peter MacCallum and a PhD student in the Cancer Immunology Program in the Neeson Lab.
